Home › Funds › Siren, L.L.C. › TYRA
Siren, L.L.C. position in TYRA
Tyra Biosciences, Inc. · Health Care
Siren, L.L.C. reported holding 3,395,887 shares of TYRA (Tyra Biosciences, Inc.) in its Q3 2026 13F filing — a position valued at US$74.3M, representing 1.76% of its reported portfolio and ranking #15 among its reported holdings. Siren, L.L.C. has disclosed TYRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s TYRA position evolved
Siren, L.L.C. first disclosed a stake in TYRA in Q2 2026 at 725,000 shares (US$23.2M). The position peaked in Q3 2026 at 3,395,887 shares, worth US$74.3M. Across 2 filings, Siren, L.L.C. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,395,887 shares valued at US$74.3M — an increase of 2,670,887 shares quarter over quarter.. Notable position changes include a 368% increase in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 725.00K | $23.16M | New |
| Q3 2026 | 3.40M | $74.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TYRA and 13F data
TYRA (Tyra Biosciences, Inc.) is a Health Care company. 56 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $389.62M · Q2 2026
- Alta Partners Management Company, L.P. 3.82M sh · $122.12M · Q2 2026
- Nextech Invest Ltd. 3.55M sh · $113.50M · Q2 2026
- TCG Crossover Management, LLC 3.25M sh · $103.77M · Q2 2026
- Commodore Capital LP 1.88M sh · $59.89M · Q2 2026
- Paradigm Biocapital Advisors LP 1.83M sh · $58.41M · Q2 2026
- BVF INC/IL 1.48M sh · $47.15M · Q2 2026
- 5AM Venture Management, LLC 1.03M sh · $32.88M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.02M sh · $32.48M · Q2 2026
- Caligan Partners LP 806.99K sh · $25.78M · Q2 2026
- Canaan Partners XI LLC 750.00K sh · $23.95M · Q2 2026
- Sio Capital Management, LLC 695.32K sh · $22.21M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held TYRA?
Siren, L.L.C. has disclosed TYRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Siren, L.L.C.'s current position in TYRA?
As of Q3 2026, Siren, L.L.C. holds 3.40M shares of TYRA (Tyra Biosciences, Inc.), valued at $74.27M, representing 1.76% of its reported portfolio and ranking #15.
Has Siren, L.L.C. been buying or selling TYRA?
In the latest 13F filing (Q3 2026), Siren, L.L.C. increased its position in TYRA. The position peaked in Q3 2026 at 3.40M shares.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.